Global Psychedelic Drugs Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	233 Pages	TechNavio	May, 2025	INF20016828

Best Price Guarantee
Price	from $2,500
Length	233 Pages
Publisher	TechNavio
Published Date	May, 2025
SKU	INF20016828

Psychedelic Drugs Market 2025-2029

The psychedelic drugs market is forecasted to grow by USD 1946.2 mn during 2024-2029, accelerating at a CAGR of 14.3% during the forecast period. The report on the psychedelic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of mental health disorders, increasing acceptance and legalization of psychedelic substances, and growing government programs and initiatives focused on mental health.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's psychedelic drugs market is segmented as below:

By Type

Ketamine
GHB
MDMA
Psilocybin
Others

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Others

By Application

Treatment resistant depression
Opiate addiction

By Route Of Administration

Oral
Inhalation
Injectable

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing focus of companies on developing next-generation therapies for psychiatric disorders as one of the prime reasons driving the psychedelic drugs market growth during the next few years. Also, rising emphasis of companies on mergers and acquisitions and expanding therapeutic applications of psychedelics will lead to sizable demand in the market.

The report on the psychedelic drugs market covers the following areas:

Psychedelic Drugs Market sizing
Psychedelic Drugs Market forecast
Psychedelic Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading psychedelic drugs market vendors that include AbbVie Inc., Avadel Pharmaceuticals plc, Braxia Scientific Corp., COMPASS Pathways plc, Cybin Inc., HAVN Life Sciences Inc, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lykos Therapeutics, Pfizer Inc., Seelos Therapeutics Inc., Silo Pharma Inc., and Stella Center. Also, the psychedelic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Psychedelic Drugs Market 2019 - 2023; Historic Market Size - Data Table on Global Psychedelic Drugs Market 2019 - 2023 ($ million); 5.2 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.3 Distribution Channel segment analysis 2019 - 2023; Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); 5.4 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ million); 5.5 Route of Administration segment analysis 2019 - 2023; Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); 5.6 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.7 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on Global Psychedelic Drugs market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type: 8.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 8.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 8.3 Ketamine - Market size and forecast 2024-2029; Chart on Ketamine - Market size and forecast 2024-2029 ($ million); Data Table on Ketamine - Market size and forecast 2024-2029 ($ million); Chart on Ketamine - Year-over-year growth 2024-2029 (%); Data Table on Ketamine - Year-over-year growth 2024-2029 (%); 8.4 GHB - Market size and forecast 2024-2029; Chart on GHB - Market size and forecast 2024-2029 ($ million); Data Table on GHB - Market size and forecast 2024-2029 ($ million); Chart on GHB - Year-over-year growth 2024-2029 (%); Data Table on GHB - Year-over-year growth 2024-2029 (%); 8.5 MDMA - Market size and forecast 2024-2029; Chart on MDMA - Market size and forecast 2024-2029 ($ million); Data Table on MDMA - Market size and forecast 2024-2029 ($ million); Chart on MDMA - Year-over-year growth 2024-2029 (%); Data Table on MDMA - Year-over-year growth 2024-2029 (%); 8.6 Psilocybin - Market size and forecast 2024-2029; Chart on Psilocybin - Market size and forecast 2024-2029 ($ million); Data Table on Psilocybin - Market size and forecast 2024-2029 ($ million); Chart on Psilocybin - Year-over-year growth 2024-2029 (%); Data Table on Psilocybin - Year-over-year growth 2024-2029 (%); 8.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.8 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Distribution Channel: 9.1 Market segments; Chart on Distribution Channel - Market share 2024-2029 (%); Data Table on Distribution Channel - Market share 2024-2029 (%); 9.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 9.3 Hospital pharmacy - Market size and forecast 2024-2029; Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million); Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million); Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%); Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%); 9.4 Retail pharmacy - Market size and forecast 2024-2029; Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million); Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million); Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%); Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%); 9.5 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.6 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Application: 10.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 10.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 10.3 Treatment resistant depression - Market size and forecast 2024-2029; Chart on Treatment resistant depression - Market size and forecast 2024-2029 ($ million); Data Table on Treatment resistant depression - Market size and forecast 2024-2029 ($ million); Chart on Treatment resistant depression - Year-over-year growth 2024-2029 (%); Data Table on Treatment resistant depression - Year-over-year growth 2024-2029 (%); 10.4 Opiate addiction - Market size and forecast 2024-2029; Chart on Opiate addiction - Market size and forecast 2024-2029 ($ million); Data Table on Opiate addiction - Market size and forecast 2024-2029 ($ million); Chart on Opiate addiction - Year-over-year growth 2024-2029 (%); Data Table on Opiate addiction - Year-over-year growth 2024-2029 (%); 10.5 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
11 Market Segmentation by Route of Administration: 11.1 Market segments; Chart on Route of Administration - Market share 2024-2029 (%); Data Table on Route of Administration - Market share 2024-2029 (%); 11.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 11.3 Oral - Market size and forecast 2024-2029; Chart on Oral - Market size and forecast 2024-2029 ($ million); Data Table on Oral - Market size and forecast 2024-2029 ($ million); Chart on Oral - Year-over-year growth 2024-2029 (%); Data Table on Oral - Year-over-year growth 2024-2029 (%); 11.4 Inhalation - Market size and forecast 2024-2029; Chart on Inhalation - Market size and forecast 2024-2029 ($ million); Data Table on Inhalation - Market size and forecast 2024-2029 ($ million); Chart on Inhalation - Year-over-year growth 2024-2029 (%); Data Table on Inhalation - Year-over-year growth 2024-2029 (%); 11.5 Injectable - Market size and forecast 2024-2029; Chart on Injectable - Market size and forecast 2024-2029 ($ million); Data Table on Injectable - Market size and forecast 2024-2029 ($ million); Chart on Injectable - Year-over-year growth 2024-2029 (%); Data Table on Injectable - Year-over-year growth 2024-2029 (%); 11.6 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
12 Customer Landscape: 12.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape: 13.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 13.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 13.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 13.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 13.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 13.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 13.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 13.8 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 13.9 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 13.10 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 13.11 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 13.12 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 13.13 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 13.14 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 13.15 Brazil - Market size and forecast 2024-2029; Chart on Brazil - Market size and forecast 2024-2029 ($ million); Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Chart on Brazil - Year-over-year growth 2024-2029 (%); Data Table on Brazil - Year-over-year growth 2024-2029 (%); 13.16 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ million); Data Table on Italy - Market size and forecast 2024-2029 ($ million); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 13.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints: 14.1 Market drivers; 14.2 Market challenges; 14.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 14.4 Market opportunities/restraints
15 Competitive Landscape: 15.1 Overview; 15.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 15.3 Landscape disruption; Overview on factors of disruption; 15.4 Industry risks; Impact of key risks on business
16 Competitive Analysis: 16.1 Companies profiled; Companies covered; 16.2 Company ranking index; Company ranking index; 16.3 Market positioning of companies; Matrix on companies position and classification; 16.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; SWOT; 16.5 Avadel Pharmaceuticals plc; Avadel Pharmaceuticals plc - Overview; Avadel Pharmaceuticals plc - Product / Service; Avadel Pharmaceuticals plc - Key offerings; SWOT; 16.6 Braxia Scientific Corp.; Braxia Scientific Corp. - Overview; Braxia Scientific Corp. - Product / Service; Braxia Scientific Corp. - Key offerings; SWOT; 16.7 COMPASS Pathways plc; COMPASS Pathways plc - Overview; COMPASS Pathways plc - Product / Service; COMPASS Pathways plc - Key offerings; SWOT; 16.8 Cybin Inc.; Cybin Inc. - Overview; Cybin Inc. - Product / Service; Cybin Inc. - Key offerings; SWOT; 16.9 HAVN Life Sciences Inc; HAVN Life Sciences Inc - Overview; HAVN Life Sciences Inc - Product / Service; HAVN Life Sciences Inc - Key offerings; SWOT; 16.10 Jazz Pharmaceuticals Plc; Jazz Pharmaceuticals Plc - Overview; Jazz Pharmaceuticals Plc - Product / Service; Jazz Pharmaceuticals Plc - Key news; Jazz Pharmaceuticals Plc - Key offerings; SWOT; 16.11 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; SWOT; 16.12 Lykos Therapeutics; Lykos Therapeutics - Overview; Lykos Therapeutics - Product / Service; Lykos Therapeutics - Key offerings; SWOT; 16.13 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 16.14 Seelos Therapeutics Inc.; Seelos Therapeutics Inc. - Overview; Seelos Therapeutics Inc. - Product / Service; Seelos Therapeutics Inc. - Key offerings; SWOT; 16.15 Silo Pharma Inc.; Silo Pharma Inc. - Overview; Silo Pharma Inc. - Product / Service; Silo Pharma Inc. - Key offerings; SWOT; 16.16 Stella Center; Stella Center - Overview; Stella Center - Product / Service; Stella Center - Key offerings; SWOT
17 Appendix: 17.1 Scope of the report; 17.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 17.3 Currency conversion rates for US$; Currency conversion rates for US$; 17.4 Research methodology; Research methodology; 17.5 Data procurement; Information sources; 17.6 Data validation; Data validation; 17.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 17.8 Data synthesis; Data synthesis; 17.9 360 degree market analysis; 360 degree market analysis; 17.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Market Segmentation by Application; Exhibits8: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits9: Executive Summary - Chart on Incremental Growth; Exhibits10: Executive Summary - Data Table on Incremental Growth; Exhibits11: Executive Summary - Chart on Company Market Positioning; Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits13: Overview on criticality of inputs and factors of differentiation; Exhibits14: Overview on factors of disruption; Exhibits15: Impact of drivers and challenges in 2024 and 2029; Exhibits16: Parent Market; Exhibits17: Data Table on - Parent Market; Exhibits18: Market characteristics analysis; Exhibits19: Value chain analysis; Exhibits20: Offerings of companies included in the market definition; Exhibits21: Market segments; Exhibits22: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits24: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits26: Historic Market Size - Data Table on Global Psychedelic Drugs Market 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Application Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); Exhibits31: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits32: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits33: Five forces analysis - Comparison between 2024 and 2029; Exhibits34: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits36: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits37: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits38: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits39: Chart on Market condition - Five forces 2024 and 2029; Exhibits40: Chart on Type - Market share 2024-2029 (%); Exhibits41: Data Table on Type - Market share 2024-2029 (%); Exhibits42: Chart on Comparison by Type; Exhibits43: Data Table on Comparison by Type; Exhibits44: Chart on Ketamine - Market size and forecast 2024-2029 ($ million); Exhibits45: Data Table on Ketamine - Market size and forecast 2024-2029 ($ million); Exhibits46: Chart on Ketamine - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Ketamine - Year-over-year growth 2024-2029 (%); Exhibits48: Chart on GHB - Market size and forecast 2024-2029 ($ million); Exhibits49: Data Table on GHB - Market size and forecast 2024-2029 ($ million); Exhibits50: Chart on GHB - Year-over-year growth 2024-2029 (%); Exhibits51: Data Table on GHB - Year-over-year growth 2024-2029 (%); Exhibits52: Chart on MDMA - Market size and forecast 2024-2029 ($ million); Exhibits53: Data Table on MDMA - Market size and forecast 2024-2029 ($ million); Exhibits54: Chart on MDMA - Year-over-year growth 2024-2029 (%); Exhibits55: Data Table on MDMA - Year-over-year growth 2024-2029 (%); Exhibits56: Chart on Psilocybin - Market size and forecast 2024-2029 ($ million); Exhibits57: Data Table on Psilocybin - Market size and forecast 2024-2029 ($ million); Exhibits58: Chart on Psilocybin - Year-over-year growth 2024-2029 (%); Exhibits59: Data Table on Psilocybin - Year-over-year growth 2024-2029 (%); Exhibits60: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits61: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits62: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits63: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits64: Market opportunity by Type ($ million); Exhibits65: Data Table on Market opportunity by Type ($ million); Exhibits66: Chart on Distribution Channel - Market share 2024-2029 (%); Exhibits67: Data Table on Distribution Channel - Market share 2024-2029 (%); Exhibits68: Chart on Comparison by Distribution Channel; Exhibits69: Data Table on Comparison by Distribution Channel; Exhibits70: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million); Exhibits71: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million); Exhibits72: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%); Exhibits73: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%); Exhibits74: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million); Exhibits75: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million); Exhibits76: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%); Exhibits77: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%); Exhibits78: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits79: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits80: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits81: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits82: Market opportunity by Distribution Channel ($ million); Exhibits83: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits84: Chart on Application - Market share 2024-2029 (%); Exhibits85: Data Table on Application - Market share 2024-2029 (%); Exhibits86: Chart on Comparison by Application; Exhibits87: Data Table on Comparison by Application; Exhibits88: Chart on Treatment resistant depression - Market size and forecast 2024-2029 ($ million); Exhibits89: Data Table on Treatment resistant depression - Market size and forecast 2024-2029 ($ million); Exhibits90: Chart on Treatment resistant depression - Year-over-year growth 2024-2029 (%); Exhibits91: Data Table on Treatment resistant depression - Year-over-year growth 2024-2029 (%); Exhibits92: Chart on Opiate addiction - Market size and forecast 2024-2029 ($ million); Exhibits93: Data Table on Opiate addiction - Market size and forecast 2024-2029 ($ million); Exhibits94: Chart on Opiate addiction - Year-over-year growth 2024-2029 (%); Exhibits95: Data Table on Opiate addiction - Year-over-year growth 2024-2029 (%); Exhibits96: Market opportunity by Application ($ million); Exhibits97: Data Table on Market opportunity by Application ($ million); Exhibits98: Chart on Route of Administration - Market share 2024-2029 (%); Exhibits99: Data Table on Route of Administration - Market share 2024-2029 (%); Exhibits100: Chart on Comparison by Route of Administration; Exhibits101: Data Table on Comparison by Route of Administration; Exhibits102: Chart on Oral - Market size and forecast 2024-2029 ($ million); Exhibits103: Data Table on Oral - Market size and forecast 2024-2029 ($ million); Exhibits104: Chart on Oral - Year-over-year growth 2024-2029 (%); Exhibits105: Data Table on Oral - Year-over-year growth 2024-2029 (%); Exhibits106: Chart on Inhalation - Market size and forecast 2024-2029 ($ million); Exhibits107: Data Table on Inhalation - Market size and forecast 2024-2029 ($ million); Exhibits108: Chart on Inhalation - Year-over-year growth 2024-2029 (%); Exhibits109: Data Table on Inhalation - Year-over-year growth 2024-2029 (%); Exhibits110: Chart on Injectable - Market size and forecast 2024-2029 ($ million); Exhibits111: Data Table on Injectable - Market size and forecast 2024-2029 ($ million); Exhibits112: Chart on Injectable - Year-over-year growth 2024-2029 (%); Exhibits113: Data Table on Injectable - Year-over-year growth 2024-2029 (%); Exhibits114: Market opportunity by Route of Administration ($ million); Exhibits115: Data Table on Market opportunity by Route of Administration ($ million); Exhibits116: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits117: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits118: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits119: Chart on Geographic comparison; Exhibits120: Data Table on Geographic comparison; Exhibits121: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits142: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits143: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits146: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits147: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits149: Chart on Canada - Market size and forecast 2024-2029 ($ million)